Dr. Matthew Hardwick Joins the Airmid Healthgroup Blog as a Guest Thought Leader

We are thrilled to announce that Dr. Hardwick, a renowned expert in infection prevention and antimicrobial surface technologies, will be bringing his wealth of knowledge and experience to our community.
About Dr. Hardwick’s Background
Dr. Hardwick has led teams specialising in Good Laboratory Practice (GLP) studies and infection control. His academic research has been pivotal in advancing our understanding of antimicrobial surface technologies, which are crucial in mitigating the spread of infections.
Dr. Hardwick’s leadership extends beyond the laboratory. He actively engages with the broader scientific community, sharing his insights on the challenges in the field of infection prevention and offering valuable advice to aspiring entrepreneurs.
We are confident that Dr. Hardwick’s contributions will enrich our blog, providing our readers with in-depth analyses and discussions on GLP and infection control. Please join us in welcoming Dr. Matt Hardwick to the Airmid Healthgroup blog!
Related Tests and Sectors
Aerobiology and Infection Control Chambers
Airmid Healthgroup utilises specialised chambers to simulate indoor environments for testing the efficacy of products in controlling airborne pathogens.
Bio-Safety Level 2 Testing
Conducting testing that includes flu virus, bacteria, and mould to ensure products meet safety and efficacy standards.
Virus Testing Services
Providing comprehensive virus testing services to assess the effectiveness of various infection control products and technologies.
Have Questions About GLP or Infection Control Testing?
Contact Airmid Healthgroup to discuss GLP-aligned infection control and antimicrobial testing for your product or technology.
Frequently Asked Questions
Keyword Phrases
GLP testing for infection control; antimicrobial surface technologies; infection prevention and laboratory research; Good Laboratory Practice (GLP) compliance; pathogen control in healthcare settings; surface disinfection and antimicrobial efficacy; scientific validation of infection control products; emerging trends in microbiology and infection prevention; regulatory standards for antimicrobial testing; infection risk mitigation in indoor environments.
Keyword Tags
GLP testing, infection control, antimicrobial surfaces, pathogen prevention, laboratory research, disinfection efficacy, indoor health, regulatory compliance, microbiology innovations, infection risk mitigation.
Articles by Dr. Matthew Hardwick
Articles will be listed here as they are published.
Blog post updated by Dr Matt Hardwick 9th October 2026
Related Resources

510(k) Testing & Consulting
510(k) testing and consulting in one team: predicate strategy, test plans, eSTAR submissions and FDA responses, backed by GLP-capable laboratory testing.

Policy, MedTech Regulation & Government Affairs
MedTech regulation, policy and government affairs support from the iAIR Institute in Washington DC, alongside Airmid Healthgroup testing and research.

GUV Testing, FDA Regulations, and Honky-Tonk: Airmid at APIC 2026
Airmid Healthgroup's Matthew Hardwick reports from APIC 2026 in Nashville where GUV regulatory testing dominated the expo floor.

510(k) Cleared: The Regulatory Decisions That Actually Move the Needle
510(k) Cleared: The Regulatory Decisions That Actually Move the Needle

Stability Test Chambers
Stability Testing to Protect Product Integrity & compliance: Ensure consistent storage & shelf life; pharmaceutical, medical, & biomedical industry regulations

Strategic Biomedical Marketing & Labeling: Data-Driven Claims
We partner with marketing leadership teams to provide strategic insights that highlight the health impact of your products and services for biomedical…
